ArticleEuropean journal of epidemiology2026

A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.

Stefan Verweij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.